equity

game

Elys Game Technology Corp.

executive

CEO is worthless &amp; management has no idea.

$ELYS Our CEO is as crooked as they come.

pump-and-dump

$ELYS  what a PUMP and DUMP ongoing for all big negative number company.

This stock only pump and dump, is always a trap for people coming late.

$ELYS honestly this stock is shady as fuck looks like a pump and dumb.

$ELYS damn this could pump to over a dollar

suck

$ELYS all the other stocks I considered on Friday ah for investing are up more than 30% this fucking shit in which I invested is down😞

$ELYS that fkn cracker be spot on lately better block his trolling ass making me look bad

ALL BIG NEGATIVE NUMBERS for this company.

New shorts are trapped and face potential losses, big losses if stubborn.

short

$ELYS those naked shorts are kicking ass.

$ELYS …Don’t let the shorts fool you.

$ELYS Shorts and bears absolutely, unconditionally, completely, unquestionably OBLITERATED here. Lmaoooooooooo.

Profitability 
Profit Margin -41.88% 
Operating Margin (ttm) -24.08% 
Management Effectiveness 
Return on Assets (ttm) -12.41% 
Return on Equity (ttm) -92.70%

$ELYS 

Elys Game Technology, Corp. Common Stock (ELYS)
Nasdaq Listed

$0.2871 +0.0271 (+10.42%)
Bid: $0.2871 Ask: $0.295
Volume: 55,336
DEC 29, 2022 4:26 AM ET - PRE-MARKET

STRONG BUY OR HOLD ! !

🚨Relative Volume Increase🚨 Part 2

$ELYS $VNTR $BGRY $RENT $GAME 

Stay tune for more ideas!

news

Record-volume activity, positive reversal pattern, no short borrows, and ChatGPT news sector hype fuel excitement.

$ELYS could be “the” runner today with this news and set up

The AI sector is hot right now🔥 Manu eyes fixed on $RCRT upcoming week🚨 due to GPT integration news and CEO interview on CNBC.

$ELYS volume baby 🔥 With this news coming in, I see $2+

$GNS $HLBZ $RSLS Offering canceled by ELYS on Friday and now this great news!

$HSCS $SECO $MARK $ELYS  

HSCS good news, could see a NHOD

$ELYS well the news should put it back in a   uptrend after the sale off!

$INM looking for $3 today on news yesterday 

Other scanner first page gainers of note:
$VYNE 45%
$ELYS 42%
$HOLO 37%
$SBIG 33%
👀⬆️

bull

$ELYS the bull pattern is confirmed &amp; a BUY signal is issued @ https://bit.ly/3njUJlq.

$ELYS may go up 185% if the bull pattern is confirmed.

I was the biggest of bulls for the better part of two years.

$ELYS Top gainer today congrats to the bulls! Beautiful.

share

$ELYS so it looks like we&#39;re adding some more shares to the float. yay!

Love this one, I still have my 5000 shares.

$ELYS Looking good as far as the $1 share price.

$IVC  With a successful turn around this can easily go to 5$ 💰  💰 
-Super bullish chart 🚀 🚀 🚀 
-28% short intrest
-37.7M outstanding  shares.

but this started moving up when I bought 10K shares 😂😂😂

TOP PRE-MARKET GAINERS  
• $ELYS – shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday.

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

patient

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

$BIVI Biovie Pharmaceuticals $BIVI passes Zacks Equity Research&#39;s strict &quot;Recent Price Strength screen&quot;, and comes out with glowing colors--and a prediction of further momentum for the stock in near term.

$SAVA hay .m u can play all the games u want

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

Zimhi, loved by the professionals on the ground, game changer in the saving lifes cause, mainly fentanyl overdoses.

$SAVA more games that’s okay I can wait 💪🏼💪🏼

My prediction:
Phase 2 Unbelievable results
FDA fast track
Phase 3 - go ahead
Patients receive sava 
Market cap 40 B by 2024 
Rising to 200 Billion by 2026
Game changer - the only drug in the world to help patients

catalysts are nearing play all the game you want.

Suffice to say, it would be GAME CHANGER. .

$SAVA Sitting here with the Sunday games running and thinking how pleased I will be when the commercial plays showing lives being touched with the chance for many more quality days ahead because of Simufilam.

business-result

But the company actually has never seen before wonderful results.

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

Sensus Healthcare Inc

It is a game changer for heart patients and is being rapidly adopted by hospitals and doctors.

product

3 other approved products, all growing revenue.

This is the &quot;Holy Grail&quot; all big pharma has been searching for.

Top Stocks matching your search for "equity game"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

ELYS

Elys Game Technology Corp.

-50.82%

$1.10 - $0.54

Feb, 3, 2023

Feb, 3, 2023

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Dec, 11, 2022

SRTS

Sensus Healthcare Inc

-41.61%

$9.06 - $5.29

Jan, 21, 2023

ELYS

Elys Game Technology Corp.

-50.82%

$1.10 - $0.54

Feb, 3, 2023

Feb, 3, 2023

Feb, 3, 2023

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Dec, 11, 2022

SRTS

Sensus Healthcare Inc

-41.61%

$9.06 - $5.29